Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06093152 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Video Assisted Study of Salbutamol Response in Viral Wheezing

Study acronym: ViVi
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 2024 to Dec 2026
    • Study completion date: Dec 2025 to Dec 2026
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is video assisted cross-over study evaluating the effect of inhaled salbutamol in wheeze in children 6-24 months old.
Trial Details
NCT Number NCT06093152
Lead Sponsor University of Oulu
Conditions
(from sponsor)		 Wheezing
Related terms Respiratory Sounds
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov